Trans-Pacific Technology Fund (TPTF)
Our Mission: The Trans-Pacific Technology Fund (TPTF) is a technology-driven venture capital fund, investing in innovative companies shaping the future of global business. We work actively with the leadership of our portfolio companies from different regions of the world, supporting their growth. Our Approach: At TPTF, we believe the cornerstone of every great company is great people. Before a fascinating innovation can become a game-changing company on a global scale, we believe there needs to be daring entrepreneurs to convert the concept into reality. In addition to providing capital, we consider ourselves a committed partner, supporting our entrepreneurs via our extensive international resources, deep domain expertise and, most importantly, our passion to work together to build great companies. Our Focus Area: We invest in disruptive, platform technologies focusing on the sectors where we have leading domain expertise, including but not limited to: advanced materials, health/life sciences, ICT, IOT and robotics/automation. We have a multi-stage investment strategy to work with companies ranging from early to expansion/late stage. Through our extensive network of collaborative partners around the world, we have a global investment scope, seeking to invest in companies across Asia, North America and Europe.
Rey.id is a new kind of insurance which serves you like your family doctor -- all from your gadget. We believe that insurance products can bring a better impression, not only as a means to play your health risk claims, but also serve a complete healthcare service, as well as improving your quality of life. Rey is the first health and life insurance provider in Indonesia that is designed in a technology platform, as well as serves as an integrated digital healthcare ecosystem. Unlike your usual insurance products, Rey focuses on the quality of healthcare services and well-being of our members. Rey does not want to be transactional, but also transformational in helping you achieving a healthy life. We started Rey in 2021. We are a team of people with different backgrounds, expertises, and experiences, yet with the same purpose -- To reimagine and to democratize life & health insurance in Indonesia. We realize that today life & health insurance is a product that people need, but not a product that people want. Therefore, we design Rey as a life & health insurance product that we would want for ourselves -- A (w)holistic protection, technology-driven, focus on healthcare quality and our wellbeing, and never be a hassle.
Rey.id is a new kind of insurance which serves you like your family doctor -- all from your gadget. We believe that insurance products can bring a better impression, not only as a means to play your health risk claims, but also serve a complete healthcare service, as well as improving your quality of life. Rey is the first health and life insurance provider in Indonesia that is designed in a technology platform, as well as serves as an integrated digital healthcare ecosystem. Unlike your usual insurance products, Rey focuses on the quality of healthcare services and well-being of our members. Rey does not want to be transactional, but also transformational in helping you achieving a healthy life. We started Rey in 2021. We are a team of people with different backgrounds, expertises, and experiences, yet with the same purpose -- To reimagine and to democratize life & health insurance in Indonesia. We realize that today life & health insurance is a product that people need, but not a product that people want. Therefore, we design Rey as a life & health insurance product that we would want for ourselves -- A (w)holistic protection, technology-driven, focus on healthcare quality and our wellbeing, and never be a hassle.
Rey.id
Pre Seed Round in 2021
Rey.id is a new kind of insurance which serves you like your family doctor -- all from your gadget. We believe that insurance products can bring a better impression, not only as a means to play your health risk claims, but also serve a complete healthcare service, as well as improving your quality of life. Rey is the first health and life insurance provider in Indonesia that is designed in a technology platform, as well as serves as an integrated digital healthcare ecosystem. Unlike your usual insurance products, Rey focuses on the quality of healthcare services and well-being of our members. Rey does not want to be transactional, but also transformational in helping you achieving a healthy life. We started Rey in 2021. We are a team of people with different backgrounds, expertises, and experiences, yet with the same purpose -- To reimagine and to democratize life & health insurance in Indonesia. We realize that today life & health insurance is a product that people need, but not a product that people want. Therefore, we design Rey as a life & health insurance product that we would want for ourselves -- A (w)holistic protection, technology-driven, focus on healthcare quality and our wellbeing, and never be a hassle.
Prixa is a pioneering digital healthcare company based in Jakarta, Indonesia, founded in 2019. It offers a comprehensive health management platform that integrates various healthcare services into a single accessible ecosystem. Utilizing artificial intelligence, Prixa provides teleconsultation, doctor appointments, pharmacy delivery, lab tests, and health-related content. The platform caters primarily to healthcare payers, including insurance companies, corporations, and governmental entities, with the aim of humanizing health management and making healthcare more affordable. Through its innovative approach, Prixa enables users to effectively manage their health while reducing claims and overall healthcare costs.
Finch Therapeutics
Series D in 2020
Finch Therapeutics is a microbiome technology company focused on developing microbial therapies for patients with serious medical needs. The company utilizes donor-derived Full-Spectrum Microbiota and Rationally-Selected Microbiota platforms to create complete microbiome communities aimed at restoring functionality and addressing conditions caused by microbiome disruption. Finch offers oral microbiome treatments targeting recurrent C. difficile infections, chronic hepatitis B, inflammatory bowel disease, and gastrointestinal symptoms in children with autism. By employing machine learning algorithms, Finch analyzes clinical data to identify effective microbial combinations, thereby minimizing translational risks associated with drug development. Founded in 2017 and headquartered in Somerville, Massachusetts, Finch Therapeutics holds a significant portfolio of intellectual property, including over 70 patents related to microbiome therapeutics.
Finch Therapeutics
Series C in 2019
Finch Therapeutics is a microbiome technology company focused on developing microbial therapies for patients with serious medical needs. The company utilizes donor-derived Full-Spectrum Microbiota and Rationally-Selected Microbiota platforms to create complete microbiome communities aimed at restoring functionality and addressing conditions caused by microbiome disruption. Finch offers oral microbiome treatments targeting recurrent C. difficile infections, chronic hepatitis B, inflammatory bowel disease, and gastrointestinal symptoms in children with autism. By employing machine learning algorithms, Finch analyzes clinical data to identify effective microbial combinations, thereby minimizing translational risks associated with drug development. Founded in 2017 and headquartered in Somerville, Massachusetts, Finch Therapeutics holds a significant portfolio of intellectual property, including over 70 patents related to microbiome therapeutics.
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.
Heal is a healthcare provider focused on delivering value-based, in-home primary care primarily to seniors on Medicare and select Medicare Advantage plans. The company emphasizes the importance of patient comfort by offering services in the familiar environment of patients' homes. Board-certified doctors and nurse practitioners at Heal dedicate ample time to each patient, fostering strong relationships and ensuring thorough, unrushed care. Heal addresses a wide range of healthcare needs, from preventive services like flu shots and annual physicals to the management of chronic conditions and treatment of common illnesses. Additionally, the company provides telemedicine options and remote health monitoring, facilitating easy access to care when needed. Patients can schedule appointments conveniently through phone support, with availability seven days a week, including weekends and holidays.
Kata.ai is an Indonesian Conversational Artificial Intelligence company with a focus on enhancing the understanding of human conversations, improving the way humans collaborate with machines. Kata.ai’s Natural Language Processing (NLP) technology powers intelligent chatbots (virtual customer service / virtual friend) for major corporations in Indonesia across a different kind of industries such as Unilever (FMCG) and Telkomsel (Telco). The company’s proprietary Kata Bot Platform can be leveraged to create engaging chatbots on top of Kata.ai’s robust and scalable AI technology platform, ensuring company of any size can easily build their own chatbot on any messaging platform. Established in 2015, the company has become a trusted partner for major corporations such as Microsoft, Accenture, and Line. In 2017, the company also received Series-A funding led by Trans-Pacific Technology Fund.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.